Probable occurrence of IgE in the adult domestic fowl (Gallus domesticus) after horse serum stimulation

Radioimmunosorbent techniques using antisera to human immunoglobulin E (IgE) showed the presence of high levels (up to 15,840 U/ml) of IgE in serum and plásma from fowls immunised by repeated intraperitoneal injections of horse serum. These results were confirmed by passive cutaneous anaphylaxis and heat lability tests.     

A conceptual approach to the modelling of herbage intake by hill sheep

A modelling approach is examined as a method of investigating alternative management strategies for improved systems of hill sheep production. In order to take account of the wide range in the quality of hill herbage and the ability of the hill sheep to select preferred components, herbage has been conceptually classified in terms of its digestibility; the digestibility classes are then grazed selectively by sheep. The model deals with herbage growth and deterioration, diet selection and the maintenance and liveweight change of wether sheep. Results produced by the model, in which wethers grazed Agrostis-Festuca at two stocking rates, are discussed.     

Prevalence of gastrointestinal parasitism in Oklahoma swine

The prevalence of swine gastrointestinal parasites was determined from all listed large swine operations (28) and a geographically representative sample (70) of the population of small hog farm operations in Oklahoma. Fecal samples (n = 975) were collected from 98 farms. From the 98 farms, parasites were recovered in pig feces as follows: Ascaris, 53.0%, strongyles, 53.1%, Trichuris, 35.7%, spirurids, 6.1%, Strongyloides, 19.4%, coccidia, 57.1%, and Balantidium, 55.1%. A higher percentage (16.5%) of hogs maintained on cement floors were positive for Ascaris than were those on either dirt lots (11.9%) or slatted floors (9.9%), but pigs on dirt lots were more often positive with a higher percentage of coccidia (21.0%) than those on either cement or slatted floors (8.5% and 6.0%, respectively). Prevalence of Trichuris was essentially the same (6.8% to 11.3%) in hogs from all 3 management practices.     

Effects of dietary lysine and energy density on performance and carcass characteristics of finishing pigs fed ractopamine

Two hundred sixteen crossbred barrows and gilts (84.3 kg BW) were used to test the effects of dietary energy density and lysine:energy ratio (Lys:ME) on the performance, carcass characteristics, and pork quality of finishing pigs fed 10 ppm ractopamine. Pigs were blocked by BW and gender, allotted to 36 pens (six pigs per pen), and pens were assigned randomly within blocks to dietary treatments (as-fed basis) arranged in a 2 x 3 factorial design, with two levels of energy (3.30 or 3.48 Mcal/kg) and three Lys:ME (1.7, 2.4, or 3.1 g lysine/Mcal) levels. Pigs were fed experimental diets for 28 d, and weights and feed disappearance were recorded weekly to calculate ADG, ADFI, and G:F. Upon completion of the feeding trial, pigs were slaughtered and carcass data were collected before fabrication. During carcass fabrication, hams were analyzed for lean composition using a ham electrical conductivity (TOBEC) unit, and loins were collected, vacuum-packaged, and boxed for pork quality data collection. Energy density had no (P > 0.22) effect on ADG or ADFI across the entire 28-d feeding trial; however, pigs fed 3.48 Mcal of ME were more (P < 0.02) efficient than pigs fed 3.30 Mcal of ME. In addition, ADG and G:F increased linearly (P < 0.01) as Lys:ME increased from 1.7 to 3.1 g/Mcal. Carcasses of pigs fed 3.48 Mcal of ME were fatter at the last lumbar vertebrae (P < 0.08) and 10th rib (P < 0.04), resulting in a lower (P < 0.03) predicted fat-free lean yield (FFLY). Conversely, 10th-rib fat thickness decreased linearly (P = 0.02), and LM depth (P < 0.01) and area (P < 0.01) increased linearly, with increasing Lys:ME. Moreover, FFLY (P < 0.01) and actual ham lean yield (P < 0.01) increased as Lys:ME increased in the diet. Dietary energy density had no (P > 0.19) effect on pork quality, and Lys:ME did not (P > 0.20) affect muscle pH, drip loss, color, and firmness scores. Marbling scores, as well as LM lipid content, decreased linearly (P < 0.01) as Lys:ME increased from 1.7 to 3.1 g/Mcal. There was a linear (P < 0.01) increase in shear force of cooked LM chops as Lys:ME increased in the finishing diet. Results indicate that 3.30 Mcal of ME/kg (as-fed basis) is sufficient for optimal performance and carcass leanness in pigs fed ractopamine. The Lys:ME for optimal performance and carcass composition seems higher than that currently used in the swine industry; however, feeding very high Lys:ME (> 3.0 g/Mcal, as-fed basis) to ractopamine-fed pigs may result in decreased marbling and cooked pork tenderness.     

Effect of supplemental manganese on performance and carcass characteristics of growing-finishing swine

Three hundred sixteen crossbred pigs were used in two experiments to determine the effect of supplemental manganese source and dietary inclusion level during the growing-finishing period on performance and pork carcass characteristics. All pigs were blocked by weight, and treatments were assigned randomly to pens within blocks. In Exp. 1, a total of 20 pens (five pigs/pen) was randomly assigned to one of five dietary treatments consisting of control grower and finisher diets, or control diets supplemented with either 350 or 700 ppm (as-fed basis) Mn either from MnSO4 or a Mn AA complex (MnAA). In Exp. 2, a total of 36 pens (six pigs per pen) was assigned randomly to one of six dietary treatments formulated with 0, 20, 40, 80, 160, or 320 ppm (as-fed basis) Mn from MnAA. Pigs were slaughtered when the lightest block averaged 120.0 kg (Exp. 1) or at a mean BW of 106.8 kg (Exp. 2). Neither ADG nor ADFI was affected (P > 0.21) by Mn source or high inclusion level (Exp. 1); however, across the entire feeding trial, pigs consuming 320 ppm Mn from MnAA were more (P < 0.04) efficient than pigs fed diets formulated with 20 to 160 ppm Mn from MnAA (Exp. 2). Color scores did not differ (P > 0.79) at the low inclusion (20 to 320 ppm Mn) levels used in Exp. 2; however, in Exp. 1, the LM from pigs fed Mn tended to receive higher (P = 0.10) American color scores than that of pigs fed the control diet, and Japanese color scores were higher for the LM from pigs fed diets containing 350 ppm Mn from MnAA than 350 Mn from ppm MnSO4 or 700 ppm Mn from MnAA (source x inclusion level; P = 0.04; Exp. 2). Chops of pigs fed 350 ppm Mn from MnAA were darker than the LM of pigs fed 350 ppm Mn from MnSO4, and 700 ppm Mn from MnAA diets (source x inclusion level; P = 0.03; Exp. 1), but L* values were not (P = 0.76) affected by lower MnAA inclusion levels (Exp. 2). Even though the LM tended to became redder as dietary MnAA inclusion level increased from 20 to 320 ppm Mn (linear effect; P < 0.10), a* values were not (P = 0.71) altered by including 350 or 700 ppm Mn (Exp. 1). Chops of pigs fed MnAA had lower cooking losses (P = 0.01) and shear force values (P = 0.07) after 2 d of aging than did chops from pigs fed diets formulated with MnSO4. Results from these experiments indicate that feeding 320 to 350 ppm Mn from MnAA during the growing-finishing period may enhance pork quality without adversely affecting pig performance or carcass composition.     

Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses

The purpose of the study reported here was to describe the bioavailability and pharmacokinetics of acyclovir after intravenous and oral administration to horses. Six healthy adult horses were used in a randomized cross-over study with a 3 x 3 Latin square design. Three treatments were administered to each horse: 10 mg of injectable acyclovir/kg of body weight in 1 L of normal saline delivered as an infusion over 15 minutes; 10 mg of acyclovir/kg in tablets by nasogastric intubation; and 20 mg of acyclovir/kg in tablets by nasogastric intubation. A 2-week washout period was provided between each treatment. Serum samples were obtained for acyclovir assay using reversed-phase, high-performance liquid chromatography with fluorescence detection. Deproteinated serum was injected onto a C18 column, and elution occurred under isocratic conditions. The limit of quantification was 0.04 microg/mL. The assay exhibited suitable accuracy, precision, and recovery. The IV data were analyzed by a 3-compartment model, and oral data were analyzed noncompartmentally. Intragastric acyclovir administration at either dose was associated with high variability in serum acyclovir-time profiles, low Cmax, and poor bioavailability. The dosage of 20 mg/kg was associated with mean (+/- SD) Cmax of 0.19 +/- 0.10 microg/mL, and bioavailability was 2.8%. Inhibition of equine herpesvirus has been reported to require significantly higher acyclovir concentrations than those obtained here. The results of this study do not support a therapeutic benefit for the oral administration of acyclovir up to doses of 20 mg/kg.     

Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite after oral and intravenous administration of pentoxifylline to healthy adult horses

OBJECTIVE: To determine serum pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite in horses after administration of a single IV dose and after single and multiple oral doses. ANIMALS: 8 healthy adult horses. PROCEDURES: A crossover study design was used with a washout period of 6 days between treatments. Treatments were IV administration of a single dose of pentoxifylline (8.5 mg/kg) and oral administration of generic sustained-release pentoxifylline (10 mg/kg, q 12 h, for 8 days). Blood samples were collected 0, 1, 3, 6, 12, 20, 30, and 45 minutes and 1, 2, 4, 6, 8, and 12 hours after IV administration. For oral administration, blood samples were collected 0, 0.25, 0.5, 0.75, 1, 2, 4, 8, and 12 hours after the first dose and 0, 0.25, 0.5, 0.75, 1, 2, 4, 8, 12, and 24 hours after the last dose. RESULTS: Elimination of pentoxifylline was rapid after IV administration. After oral administration, pentoxifylline was rapidly absorbed and variably eliminated. Higher serum concentrations of pentoxifylline and apparent bioavailability were observed after oral administration of the first dose, compared with values after administration of the last dose on day 8 of treatment. CONCLUSIONS AND CLINICAL RELEVANCE: In horses, oral administration of 10 mg of pentoxifylline/kg results in serum concentrations equivalent to those observed for therapeutic doses of pentoxifylline in humans. Twice daily administration appears to be appropriate. However, serum concentrations of pentoxifylline appear to decrease with repeated dosing; thus, practitioners may consider increasing the dosage if clinical response diminishes with repeated administration.